Jefferies Cuts Price Target on PG&E Corp. (PCG) to $70.00 Following CPUC Testimony
- Amazon, health stocks weigh on S&P, Nasdaq; Chevron lifts Dow
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Jefferies maintained a Buy rating on PG&E Corporation (NYSE: PCG), and cut the price target to $70.00 (from $71.50), following the CPUC testimony in PCG's TO18 rate case. The CPUC took issue with, among other things, PG&E's calculation of its base ROE, which the CPUC said was calculated incorrectly, and the 50 bps RTO participation adder. In TO16 and TO17, the CPUC made a nearidentical filing as well as requests for rehearing. In all three cases, the FERC rejected the CPUC request to deny the CAISO adder.
Analyst Anthony Crowdell commented, "On 8/19, the CPUC filed testimony in PCG's TO18 rate case at the FERC arguing, among other issues, that PG&E's requested base ROE was incorrectly calculated and is too high, and that PG&E's 50 bps RTO adder should not be summarily authorized. We don't believe the FERC will take issue with the base ROE or adder, and do not see the CPUC filing as heightened risk of a lower ROE when the CA utilities file for '18 cost of capital in April."
Shares of PG&E Corporation closed at $62.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Partners Downgrades McKesson (MCK) to Market Perform
- Oppenheimer Remains Bullish on Expedia (EXPE) Following 3Q
- Alphabet (GOOGL) (GOOG) PT Lifted to $1000 at Oppenheimer
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!